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Abtract—This statement provides a concise list of diagnostic terms for ECG interpretation that can be shared by students, teachers, and readers
of electrocardiography. This effort was motivated by the existence of multiple automated diagnostic code sets containing imprecise and
overlapping terms. An intended outcome of this statement list is greater uniformity of ECG diagnosis and a resultant improvement in patient care.
The lexicon includes primary diagnostic statements, secondary diagnostic statements, modifiers, and statements for the comparison of ECGs. This
diagnostic lexicon should be reviewed and updated periodically. (J Am Coll Cardiol 2007;49:1128–35)
Key Words: AHA Scientific Statements  electrocardiography  computers  diagnosis
This is the second of 6 articles designed to upgrade theguidelines for the standardization and interpretation of
the ECG. The project was initiated by the American Heart
Association and has been endorsed by the American College
of Cardiology, the Heart Rhythm Society, and the Interna-
tional Society for Computerized Electrocardiography. The
rationale for this upgrade and a description of the process are
contained in Part I by Kligfield et al (1).
The listing contained in the present statement seeks to present
a limited set of ECG diagnostic statements that are clinically
useful and that do not create unnecessary overlap or contain
vague terminology. Some statements that are commonly used by
electrocardiographers but that do not provide diagnostically or
clinically useful information are not included. Some statements
have been excluded to reduce the size of the statement set, so
long as their meaning is well represented by included terms.
The Writing Group believes that the listing should be imple-
mented as an available lexicon in report algorithms of the
existing commercial electrocardiographs and that it should be
used widely by ECG readers. The principal advantage of such
use would be a worldwide improvement in uniformity of ECG
interpretation. Such uniformity would promote better patient
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care. Additional advantages would be facilitation of the estab-
lishment of a uniform teaching curriculum in electrocardiogra-
phy, availability of a uniform glossary of terms for research
application, and promotion of research to better validate diag-
nostic criteria for the specific terms in the limited lexicon.
Although we recognize that each vendor of ECGs possesses a
proprietary set of diagnostic statements and underlying criteria,
we hope that this list of statements will be made available by
each of them so that the reader can select it as the primary
dictionary for use in interpreting all or some ECGs. We are also
hopeful that the vendors will collaborate among themselves to
align diagnostic criteria for this specific lexicon. This would not
interfere with continued development of entirely independent,
proprietary diagnostic software by each manufacturer.
Organization and Use
Four lists are included within this document. The main listing
(Table 1), “Primary Statements,” displays 117 primary diagnos-
tic statements under 14 categories. The majority of the primary
statements are nondescriptive and convey clinical meaning
without additional statements. The second listing (Table 2),
“Secondary Statements,” provides additional statements that can
be used to expand the specificity and clinical relevance of both
descriptive and other primary diagnostic statements. These
secondary statements are divided into 2 groups. Those that are
preceded by “suggests” invoke clinical diagnoses likely respon-
sible for the ECG observation(s). Those that are preceded by
“consider” are intended to propose at least 1, but sometimes1,
potentially associated clinical disorder. This set of primary and
secondary diagnostic statements constitutes what we might call
the “core statement lexicon.”
The third list (Table 3) contains adjectives that can be used
to modify the diagnostic statements. None of the modifiers
change the meaning of the core statement but rather serve to
refine the meaning. The list contains general modifiers, which
can be used with many of the core statements, and specific
modifiers assigned to a specific category of statements.
The fourth list (Table 4) is a short directory of comparison
statements. It specifies 6 types of ECG changes that merit
mention in the ECG interpretation and defines criteria to
identify change within the 6 categories. Because so many
statements could be made in comparing individual ECGs to
1 previous ECGs, the Writing Group recommends use of
these 6 statements to convey clinically important information
that could influence patient care by the attending physician
while preserving brevity and uniformity. On the other hand,
the Writing Group encourages readers to add uncoded text as
needed to the report to more fully compare tracings.
Tables 5, 6, and 7 establish rules for use of the primary,
secondary, and modifier statements, alone or in combination.
Table 8 is a set of commonly used statements that can, for the
most part, be precisely reproduced by use of the primary and
secondary statements and their modifiers. These statements are
commonly used concatenations provided for the convenience of
the reader.
Criteria for Diagnoses
This listing does not specify diagnostic criteria for any of the
statements. A single set of diagnostic criteria underlying the
core statements would have great benefits for patient care and
research. Although the Writing Group does not believe that a
uniform criterion set can be achieved at this time, we
encourage ECG vendors and electrocardiography researchers
and experts to collaborate on the development of a univer-
sally acceptable criteria set and a means for perpetually
refining it. Several of the chapters in this statement support
specific criteria for some of the core statements.
Myocardial Infarction Terminology
Advanced imaging techniques, including echocardiography
(2) and magnetic resonance (3,4), have demonstrated a need
for change in existing terminology describing the cardiac
location of myocardial infarction. New diagnostic statements
for 6 common, distinct cardiac locations of myocardial
infarction, documented by contrast-enhanced magnetic reso-
nance, were recently recommended by a committee of the
International Society for Holter and Noninvasive Electrocar-
diography (5). At the present time, the Writing Group
considers the quantity of new data insufficient to recommend
abandonment of existing terminology. Thus, traditional terms
are listed in “Section M: Myocardial infarction” of the
primary statement table (Table 1); however, we intend to
revisit this issue when sufficient data have been developed.
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TABLE 1. Primary Statements
A. Overall interpretation
1
2
3
4
B. Technical conditions
10
11
12
13
14
15
16
C. Sinus node rhythms and arrhythmias
20
21
22
23
24
25
26
27
D. Supraventricular arrhythmias
30
31
32
33
34
35
36
37
38
39
40
41
42
E. Supraventricular tachyarrhythmias
50
51
52
53
54
55
56
F. Ventricular arrhythmias
60
61
62
63
64
65
66
Normal ECG
Otherwise normal ECG
Abnormal ECG
Uninterpretable ECG
Extremity electrode reversal
Misplaced precordial electrode(s)
Missing lead(s)
Right-sided precordial electrode(s)
Artifact
Poor-quality data
Posterior electrode(s)
Sinus rhythm
Sinus tachycardia
Sinus bradycardia
Sinus arrhythmia
Sinoatrial block, type I
Sinoatrial block, type II
Sinus pause or arrest
Uncertain supraventricular rhythm
Atrial premature complex(es)
Atrial premature complexes,
nonconducted
Retrograde atrial activation
Wandering atrial pacemaker
Ectopic atrial rhythm
Ectopic atrial rhythm, multifocal
Junctional premature complex(es)
Junctional escape complex(es)
Junctional rhythm
Accelerated junctional rhythm
Supraventricular rhythm
Supraventricular complex(es)
Bradycardia, nonsinus
Atrial fibrillation
Atrial flutter
Ectopic atrial tachycardia, unifocal
Ectopic atrial tachycardia, multifocal
Junctional tachycardia
Supraventricular tachycardia
Narrow-QRS tachycardia
Ventricular premature complex(es)
Fusion complex(es)
Ventricular escape complex(es)
Idioventricular rhythm
Accelerated idioventricular rhythm
Fascicular rhythm
Parasystole
G. Ventricular tachyarrhythmias
70
71
72
73
74
75
76
H. Atrioventricular conduction
80
81
82
83
84
85
86
87
88
89
I. Intraventricular and intra-atrial
conduction
100
101
102
104
105
106
107
108
109
110
111
J. Axis and voltage
120
121
122
123
124
125
128
131
K. Chamber hypertrophy or
enlargement
140
141
142
143
144
Ventricular tachycardia
Ventricular tachycardia, unsustained
Ventricular tachycardia, polymorphous
Ventricular tachycardia, torsades de
pointes
Ventricular fibrillation
Fascicular tachycardia
Wide-QRS tachycardia
Short PR interval
AV conduction ratio N:D
Prolonged PR interval
Second-degree AV block, Mobitz type I
(Wenckebach)
Second-degree AV block, Mobitz type II
2:1 AV block
AV block, varying conduction
AV block, advanced (high-grade)
AV block, complete (third-degree)
AV dissociation
Aberrant conduction of supraventricular
beat(s)
Left anterior fascicular block
Left posterior fascicular block
Left bundle-branch block
Incomplete right bundle-branch block
Right bundle-branch block
Intraventricular conduction delay
Ventricular preexcitation
Right atrial conduction abnormality
Left atrial conduction abnormality
Epsilon wave
Right-axis deviation
Left-axis deviation
Right superior axis
Indeterminate axis
Electrical alternans
Low voltage
Abnormal precordial R-wave progression
Abnormal P-wave axis
Left atrial enlargement
Right atrial enlargement
Left ventricular hypertrophy
Right ventricular hypertrophy
Biventricular hypertrophy
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TABLE 2. Secondary Statements
Suggests  
200 Acute pericarditis
201 Acute pulmonary embolism
202 Brugada abnormality
203 Chronic pulmonary disease
204 CNS disease
205 Digitalis effect
206 Digitalis toxicity
207 Hypercalcemia
208 Hyperkalemia
209 Hypertrophic cardiomyopathy
210 Hypocalcemia
211 Hypokalemia or drug effect
212 Hypothermia
213 Ostium primum ASD
214 Pericardial effusion
215 Sinoatrial disorder
Consider  
220 Acute ischemia
221 AV nodal reentry
222 AV reentry
223 Genetic repolarization abnormality
224 High precordial lead placement
225 Hypothyroidism
226 Ischemia
227 Left ventricular aneurysm
228 Normal variant
229 Pulmonary disease
230 Dextrocardia
231 Dextroposition
CNS indicates central nervous system; ASD, atrial septal defect; and AV,
atrioventricular.
TABLE 1. Primary Statements, Cont’d
L. ST segment, T wave, and U
wave
145 ST deviation
146 ST deviation with T-wave change
147 T-wave abnormality
148 Prolonged QT interval
149 Short QT interval
150 Prominent U waves
151 Inverted U waves
152 TU fusion
153 ST-T change due to ventricular
hypertrophy
154 Osborn wave
155 Early repolarization
M. Myocardial infarction
160 Anterior MI
161 Inferior MI
162 Posterior MI
163 Lateral MI
165 Anteroseptal MI
166 Extensive anterior MI
173 MI in presence of left bundle-branch
block
174 Right ventricular MI
N. Pacemaker
180 Atrial-paced complex(es) or rhythm
181 Ventricular-paced complex(es) or rhythm
182 Ventricular pacing of non–right ventricular
apical origin
183 Atrial-sensed ventricular-paced
complex(es) or rhythm
184 AV dual-paced complex(es) or rhythm
185 Failure to capture, atrial
186 Failure to capture, ventricular
187 Failure to inhibit, atrial
188 Failure to inhibit, ventricular
189 Failure to pace, atrial
190 Failure to pace, ventricular
AV indicates atrioventricular; MI, myocardial infarction.
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TABLE 3. Modifiers
General Myocardial infarction, cont’d
301 Borderline 332 Old
303 Increased 333 Of indeterminate age
304 Intermittent 334 Evolving
305 Marked Arrhythmias and tachyarrhythmias
306 Moderate 340 Couplets
307 Multiple 341 In a bigeminal pattern
308 Occasional 342 In a trigeminal pattern
309 One 343 Monomorphic
310 Frequent 344 Multifocal
312 Possible 345 Unifocal
313 Postoperative 346 With a rapid ventricular response
314 Predominant 347 With a slow ventricular response
315 Probable 348 With capture beat(s)
316 Prominent 349 With aberrancy
317 (Specified) Lead(s) 350 Polymorphic
318 (Specified) Electrode(s) Repolarization abnormalities
321 Nonspecific 360 0.1 mV
General: conjunctions 361 0.2 mV
302 Consider 362 Depression
310 Or 363 Elevation
320 And 364 Maximally toward lead
319 With 365 Maximally away from lead
322 Versus 366 Low amplitude
Myocardial infarction 367 Inversion
330 Acute 369 Postpacing (anamnestic)
331 Recent
TABLE 4. Comparison Statements
Code Statement Criteria
400 No significant change Intervals (PR, QRS, QTc) remain normal or within 10% of a previously abnormal value
No new or deleted diagnoses with the exception of normal variant diagnoses
401 Significant change in rhythm New or deleted rhythm diagnosis
HR change 20 bpm and 50 or 100 bpm
New or deleted pacemaker diagnosis
402 New or worsened ischemia or infarction Added infarction, ST-ischemia, or T-wave-ischemia diagnosis, or worsened ST deviation or
T-wave abnormality
403 New conduction abnormality Added AV or IV conduction diagnosis
404 Significant repolarization change New or deleted QT diagnosis
New or deleted U-wave diagnosis
New or deleted nonischemic ST or T-wave diagnosis
Change in QTc 60 ms
405 Change in clinical status New or deleted diagnosis from Axis and Voltage, Chamber Hypertrophy, or Enlargement
primary statement categories or “Suggests  ” secondary statement category
406 Change in interpretation without significant change in
waveform
Used when a primary or secondary statement is added or removed despite no real change in
the tracing; ie, an interpretive disagreement exists between the readers of the first and
second ECGs
QTc indicates corrected QT interval; HR, heart rate; bpm, beats per minute; AV, atrioventricular; and IV, intraventricular.
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TABLE 5. General Use Rules
1 Secondary statements must be accompanied by a primary statement
2 Modifiers must be accompanied by a primary statement
3 A primary statement may be accompanied by nothing, by 1
modifiers, by 1 secondary statements, or by both.
4 Each secondary statement can accompany only certain primary
statements (see Table 6)
5 Each general modifier can accompany only certain primary statements
(see Table 7)
6 Each specific modifier can accompany only primary statements within
its category
TABLE 6. Secondary–Primary Statement Pairing Rules
Secondary Code May Accompany These Primary Codes
200 145–147
201 21, 105, 109, 120, 131, 141, 145–147
202 105, 106, 145–146
203 109, 120, 125, 128, 131, 141, 143
204 147
205 145–147
206 145–147
207 149
208 147
209 142
210 148
211 147–148, 150
212 14, 154
213 82, 105–106, 121
214 124
215 42, 131, 145–147
220 145–147, 151
221 55, 56
222 55, 56
223 148, 149
224 128
225 22, 24–26, 37, 38
226 145–147
227 145–147
228 80, 105, 128, 155
229 109, 120, 122–123, 125, 128, 131, 141, 143
230 128, 131
231 128
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TABLE 7. General Modifier–Primary Statement Pairing Rules*
General Modifier
Code
May (May Not) Accompany These Primary Codes or May Be
Between Codes in These Categories or Groups of Categories
May/
May Not Location
301 1–20, 24–76, 81, 83–106, 108, 122–124 May not b
302 1–3, 12–16, 80–82, 111–130, 145–152 May not b, i
303 30, 31, 36, 37, 41, 60, 62, 63, 82, 107, 109, 110 May a, b
304 21–26, 30–76, 80, 82–108, 124, 180–190 May b
305 1–20, 27–76, 81, 85–106, 111, 122, 123, 148–150, 160–190 May not b
306 1–20, 27–76, 81, 85–106, 111, 122, 123, 148–150, 160–190 May not b
307 26, 30, 31, 36, 37, 41, 60–62, 185–190 May b
308 26, 30, 31, 36, 37, 41, 60–62, 185–190 May b
309 26, 30, 31, 36, 37, 41, 60–62, 185–190 May b
310 C, D, E, F, G, N, H, I, J, K, L, M May i
312 1–3, 15, 80–82, 120–122, 128 May not b
313 145–147 May b
314 20–23, 33–35, 38–56, 63–76, 83–89, 180–184 May b
315 1–3, 15, 80–82, 120–122, 128 May not b
316 1–20, 27–76, 81, 85–106, 111, 122, 123, 148–150, 160–190 May not b
317 C, D, E, F, G, N, H, I, J, K, L, M May i
318 C, D, E, F, G, N, H, I, J, K, L, M May i
319 C, D, E, F, G, N, 100, J, K, L, M May i
321 40, 55, 56, 145–147 May b
b indicates before; a, after; and i, between.
*Not inclusive.
TABLE 8. Convenience Statements*
Code Statement
500 Nonspecific ST-T abnormality
501 ST elevation
502 ST depression
503 LVH with ST-T changes
Others to be added
LVH indicates left ventricular hypertrophy.
*This table will be developed independently by each ECG laboratory.
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